The Conrad Program gets $100M for HIV prevention
Washington Business Journal - by Tierney Plumb Staff Reporter
The Conrad Program of the Eastern Virginia Medical School received a $100 million award from the U.S. Agency for International Development to continue its development work on microbicides, or products that prevent sexual transmission of HIV.
To date, the agency has awarded a total of $160 million to the Arlington-based program for such research on microbicides, which may also be able to prevent other sexually transmitted infections.
The cooperative agreement will support five years of research, with a focus on continued clinical testing of several microbicide candidates in trials.
“Conrad has particular expertise in preclinical and early clinical research, and we are glad to see the new agreement focused on this aspect of microbicide development,” said Judy Manning, health development officer for USAID. “We are very excited about Conrad’s intention to develop combination products that provide protection not only against HIV, but also other sexually transmitted infections and unwanted pregnancy.”
Conrad is a division of the Department of Obstetrics and Gynecology at Eastern Virginia Medical School in Norfolk, where it has laboratories and a clinical research center.
Related Industry News |
Latest News |
Most Viewed Stories |
Most Emailed Stories |
